News & Updates

Patients who discontinue tenofovir alafenamide (TAF) therapy appear to have a higher hepatitis B virus relapse rate than those who ceased entecavir or tenofovir disoproxil fumarate (TDF) therapy, according to a recent study.

Eating dried fruits and oily fish appear to have positive effects on telomere length (TL), suggests a study.

The use of aspirin among pregnant patients with inflammatory bowel disease (IBD) does not appear to increase the risk of disease severity, reports a study. Low-dose aspirin (LDA) has been prescribed to nearly a third of IBD patients during pregnancy.

Contrary to routine recommendations, physical therapy (PT) does not appear to benefit individuals with knee pain due to degenerative meniscal tear, findings from the TeMPO* trial suggest.

Treatment with the pan-AKT inhibitor ipatasertib appears to induce response in patients with tumours harbouring AKT1E17K mutations, according to a study.

Switching to dolutegravir/lamivudine (DTG/3TC) or continuing bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) showed comparable virologic efficacy through 96 weeks in adults with HIV infection, according to the DYAD observational, open-label extension (OLE) study presented at IDWeek 2025.

Treatment with retatrutide demonstrates superiority over GLP-1 receptor agonists (RAs) and dual agonists (GLP-1 RAs/GIP or GCGR) in terms of weight loss in adults with overweight or obesity, but it also results in a greater risk of adverse events (AEs), according to a study.